Living and dying with metastatic bowel cancer: serial in-depth interviews with patients by Carduff, Emma et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Living and dying with metastatic bowel cancer: serial in-depth
interviews with patients
Citation for published version:
Carduff, E, Kendall, M & Murray, S 2017, 'Living and dying with metastatic bowel cancer: serial in-depth
interviews with patients', European Journal of Cancer Care. https://doi.org/10.1111/ecc.12653
Digital Object Identifier (DOI):
10.1111/ecc.12653
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
European Journal of Cancer Care
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Eur J Cancer Care 2017; e12653; wileyonlinelibrary.com/journal/ecc	 	 | 	1 of 8
DOI: 10.1111/ecc.12653
Accepted: 8 December 2016
DOI: 10.1111/ecc.12653
O R I G I N A L  A R T I C L E
Living and dying with metastatic bowel cancer: Serial in- depth 
interviews with patients
E. Carduff BN, MSc, PhD, Research Lead/Research Fellow1,2 | M. Kendall BA, PGCE, PhD, 
Senior Research Fellow2 | S.A. Murray DCH, DRCOG, MD, DFFP, FRCGP, FRCP, St Columba’s 
Hospice Chair2
1Marie Curie Hospice, Glasgow, UK
2Primary	Palliative	Care	Research	Group,	The	
Usher	Institute	of	Population	Health	
Sciences	and	Informatics,	The	University	of	
Edinburgh,	Medical	School,	Edinburgh,	UK
Correspondence
Emma	Carduff,	Marie	Curie	Hospice,	Glasgow,	
UK.
Email:	emma.carduff@mariecurie.org.uk
Funding information
Economic	and	Social	Research	Council	PhD	
Studentship	Grant
Colorectal	cancer	is	the	second	highest	cause	of	cancer	deaths.	There	are	significant	
physical	 and	psycho-	social	effects	on	quality	of	 life	with	advanced	disease.	Despite	
this,	there	are	few	accounts	of	the	patient	experience	from	advanced	illness	through	to	
dying.	We	elicited	the	longitudinal	experiences	of	living	and	dying	with	incurable	meta-
static	colorectal	cancer	by	conducting	serial	interviews	with	patients	for	12	months	or	
until	they	died.	The	interviews	were	analysed,	using	a	narrative	approach,	 longitudi-
nally	as	case	studies	and	then	together.	Thirty-	six	 interviews	with	16	patients	were	
conducted.	 Patients	 experience	 metastatic	 colorectal	 cancer	 in	 three	 phases;	 (1)	
Diagnosis	and	initial	treatment;	(2)	Deterioration	and	social	isolation	and	(3)	Death	and	
dying.	Many	patients	initially	said	they	hoped	to	survive,	but,	as	“private”	and	in-	depth	
accounts	of	the	experience	emerged	 in	further	 interviews,	so	did	the	understanding	
that	this	hope	co-	existed	with	the	knowledge	that	death	was	near.	Palliative	chemo-
therapy	and	the	challenge	of	accessing	private	accounts	of	patient	experience	can	in-
hibit	care	planning	and	prevent	patients	benefitting	from	an	active	holistic	palliative	
care	approach	earlier	in	the	disease	trajectory.	This	study	has	immediate	clinical	rele-
vance	for	health	care	professionals	in	oncology,	palliative	care	and	primary	care.
K E Y W O R D S
bowel	cancer,	narrative,	palliative	care,	palliative	chemotherapy,	qualitative	longitudinal,	
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1  | INTRODUCTION
Colorectal	 cancer	 is	 the	 fourth	most	 common	 cancer	 in	 the	United	
Kingdom	(UK),	and	the	second	highest	cause	of	cancer	death	(Cancer	
Research	UK,	 2013).	 Bowel	 cancer	 screening	 has	 reduced	 the	mor-
tality	 rate	 by	 27%	 (Libby	 et	al.,	 2012),	 but	 prognosis	 is	 poor	 in	 late	
stage	presentation	(Cancer	Research	UK,	2013).	Patients	with	Dukes’	
stage	D	cancer	have	a	5-	year	survival	rate	of	7%	compared	with	93%	
for	those	with	Dukes’	A	(National	Cancer	Intelligence	Network,	2012).	
Colorectal	 cancer	 commonly	 presents	 with	 rectal	 bleeding,	 altered	
bowel	habit	and	abdominal	pain	(Broughton,	Bailey,	&	Linney,	2004;	
Cancerbackup,	2007).	Patients	can	also	experience	faecal	incontinence,	
due	 to	 abnormal	 bowel	 functioning,	 resulting	 in	 feeling	 less	 control	
over	their	bodies	(Beech,	Arber,	&	Faithfull,	2011;	Desnoo	&	Faithfull,	
2006;	Houldin	&	Lewis,	2006;	McCaughan,	Prue,	Parahoo,	McIlfatrick,	
&	McKenna,	2011).	Fluctuations	in	psycho-	social	and	spiritual	wellbe-
ing	also	occur	as	patients	suffer	gradual	social	decline	and	seek	mean-
ing	and	purpose	 in	 their	distress	 (Murray	et	al.,	2007).	Patients	may	
also	reflect	on	life’s	value	as	the	illness	progresses	(Houldin	&	Lewis,	
2006;	 Sjovall,	Gunnars,	Olsson,	&	Thome,	 2011)	 and	 their	 sense	 of	
self	is	compromised,	which	can	result	in	social	isolation	and	existential	
distress	(Hubbard,	Kidd,	&	Kearney,	2010;	Kidd,	Kearney,	O’Carroll,	&	
This	is	an	open	access	article	under	the	terms	of	the	Creative	Commons	Attribution	License,	which	permits	use,	distribution	and	reproduction	in	any	medium,	
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Hubbard,	2008;	Little,	Jordens,	Paul,	Montgomery,	&	Philipson,	1998;	
Rozmovits	&	Ziebland,	2004;	Taylor,	2001).
The	World	 Health	 Assembly	 in	 2014	 resolved	 that	 a	 palliative	
care	approach	should	be	integrated	into	the	care	of	all	patients	with	
advanced	cancer	 (Scottish	Intercollegiate	Guidelines	Network,	2011;	
World	Health	Assembly,	2014).	However,	much	of	 the	current	 liter-
ature	 is	 focussed	 on	 the	 experiences	 of	 those	 living	with	 advanced	
cancer.	Few	of	these	studies	follow	participants	to	death	to	capture	
their	longitudinal	experiences	before	dying	(Browne	et	al.,	2011;	Little	
et	al.,	 1998;	 Ramfelt,	 Severinsson,	 &	 Lutzen,	 2002;	 Sahay,	 Gray,	 &	
Fitch,	2000;	Shaha	&	Cox,	2003;	Sjovall	et	al.,	2011).	This	has	poten-
tial	implications	for	the	development	of	interventions	to	support	this	
group	of	patients	(Cameron	&	Waterworth,	2014)	and	is	inequitable,	
as	those	with	advanced	disease	have	the	greatest	needs	and	poorer	
psycho-	social	outcomes	in	terms	of	quality	of	life,	anxiety,	depression,	
social	support,	physical,	functional	and	emotional	wellbeing	and	sat-
isfaction	with	medical	 interventions	(Simon,	Thompson,	Flashman,	&	
Wardle,	2008).	This	paper	 reports	 the	 longitudinal	experiences,	per-
ceptions	and	service	use	of	patients	with	metastatic	colorectal	cancer.
2  | METHODS
2.1 | Design
This	qualitative	study	was	underpinned	by	constructionist	and	narra-
tive	philosophies	(Crotty,	1998;	Elliott,	2005;	Frank,	1995).	We	used	
serial	in-	depth	interviews	to	understand	how	patient	experiences	and	
needs	changed	as	illness	progressed	(Kendall	et	al.,	2015;	Murray	et	al.,	
2009).	Participants	were	interviewed	over	a	year;	each	participating	in	
up	to	three	interviews.	Based	on	previous	longitudinal	studies	in	lung	
cancer	and	glioma	(Cavers	et	al.,	2012;	Kendall	&	Murray,	2005),	this	
timeframe	was	considered	appropriate	to	capture	significant	change	
in	disease	progression	and	experience.	All	procedures	performed	 in	
studies	involving	human	participants	were	in	accordance	with	the	eth-
ical	standards	of	the	national	research	committee	and	with	the	1964	
Helsinki	declaration	and	its	 later	amendments	or	comparable	ethical	
standards.	Ethical	approval	 for	 this	study	was	granted	by	the	South	
East	Scotland	research	ethics	committee	(REC	number	08/S1103/35).	
The	Consolidated	criteria	for	reporting	qualitative	research	(COREQ)	
were	used	to	report	the	study	(Tong,	Sainsbury,	&	Craig,	2007).
2.2 | Sampling and recruitment strategy
Participants	were	purposively	recruited	from	the	outpatient	clinic	of	
a	national	centre	 for	oncology	 in	Scotland	 if	 they	had	been	given	a	
diagnosis	of	metastatic	disease	within	18	months	of	the	start	of	the	
study.	Clinical	nurse	specialists	advised	the	researcher	about	poten-
tial	participants	and	the	consultant	oncologist	invited	them	to	speak	
to	the	researcher	who	explained	the	study,	provided	an	information	
sheet	 and	 offered	 to	 phone	 them	 a	 few	 days	 later.	 The	 researcher	
had	no	prior	relationship	with	the	participants	and	was	introduced	to	
the	participants	as	a	researcher.	Participants	were	excluded	if	the	re-
cruiting	clinician	considered	that	there	was	a	diagnosis	of	moderate	
to	severe	memory	impairment,	or	if	they	were	unlikely	to	survive	for	
6	months.	All	the	participants	had	been	told	that	their	cancer	was	in-
curable.	Participants	were	recruited	until	data	saturation	was	reached	
with	the	analysis	of	the	first	round	of	interviews.	Written	consent	was	
sought	before	the	first	interview	and	verbal	consent	subsequently.
2.3 | Data collection
Where	possible,	interviews	were	conducted	in	the	participants’	homes	
between	November	2008	and	July	2010.	Two	participants	requested	
the	 interviews	were	at	 the	 recruiting	centre.	We	were	given	a	quiet	
room	away	from	the	main	clinical	area.	All	interviews	were	conducted	
by	EC,	a	nurse,	with	advanced	training	in	qualitative	research	methods	
and	were	audio-	recorded	and	transcribed	verbatim.	Participants	were	
assigned	 a	 pseudonym.	A	 narrative	 approach	was	 chosen	 to	 under-
stand	the	 illness	process	through	story-	telling	 (Hyden,	1997).	Stories	
are	commonplace	in	medicine,	and	narrative	approaches	are	described	
as	inclusive,	whereby	participants	from	all	backgrounds	can	participate	
(Brown	&	Gilligan,	1992;	Reissman,	1993).	Participants	were	encour-
aged	to	tell	their	stories	in	their	own	terms	and	their	own	time.	Topics	
were	explored	as	they	arose	and	a	broad	guide	was	used	to	ensure	a	
range	of	issues	were	covered	within	each	domain	of	illness	experience	
(physical,	psychological,	social	and	spiritual).	At	subsequent	interviews,	
patients	were	asked	to	expand	on	the	issues	that	had	arisen	from	the	
previous	interview,	ensuring	an	iterative	approach,—an	essential	com-
ponent	of	contemporary	serial	interview	research	(Holland,	Thomson,	
&	Henderson,	2006).	For	example,	at	the	first	 interview,	one	partici-
pant	described	how	he	questioned	“why	me?”	when	he	was	first	diag-
nosed.	Subsequently,	following	his	observations	in	the	chemotherapy	
ward,	he	reasoned	that	cancer	affects	all	types	of	people.	 If	patients	
became	upset,	the	researcher	invited	them	to	pause	or	terminate	the	
interview.	Detailed	field	notes,	including	observations	of	the	physical	
environment,	interaction	with	participants	and	reflections	on	the	lon-
gitudinal	method	were	recorded	after	every	interview.	Analysis	of	the	
field	notes	informed	and	contextualised	the	overall	interview	analysis.
2.4 | Data analysis
Data	 were	 analysed	 at	 each	 interview	 point	 and	 then	 across	 time	
to	 elicit	 commonalities	 within	 the	 narratives.	We	 used	 Brown	 and	
Gilligan’s	Voice	Centred	Relational	Method	(VCRM)	(Brown	&	Gilligan,	
1992;	Mauthner	&	Doucet,	1998)	which	prioritises	the	participant’s	
voice	and	their	relationships,	and	encompasses	what	is	said,	and	un-
said	by	participants.	Interviews	and	transcripts	were	carefully	listened	
to	and	read	four	times	to	capture	in	detail:	(1)	Overall	plot	of	the	tran-
script	 and	 the	 researcher’s	 response	 to	 the	 story;	 (2)	How	 the	par-
ticipant	uses	pronouns	such	as	“I,”	 “you”	and	“one;”	 (3)	Participants’	
relationships	and	(4)	The	socio-	political	and	cultural	context	in	which	
the	story	is	told.
After	each	wave	(interview	1,	interview	2,	interview	3)	of	interview-
ing	was	complete	a	summary	analysis	was	written.	Then	the	summary	
analyses	were	reviewed	to	consider	issues	that	changed	over	time	for	
each	individual	participant	as	a	case	study	and	then	for	the	group	as	a	
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whole,	using	a	diagrammatical	interpretation	of	the	participants’	stories.	
The	X	axis	represented	the	time,	and	the	Y	axis	each	of	the	four	VCRM	
readings	which	not	only	displayed	what	had	changed	over	time	but	also	
how	the	themes	overlapped	and	interconnected	with	each	other.	When	
the	diagrams	for	the	group	were	completed,	compared	and	contrasted,	
they	highlighted	 that	 the	patients’	experiences	 fell	broadly	 into	 three	
stages,	which	we	have	categorised	as	themes;	(1)	diagnosis	and	initial	
treatment;	(2)	coping	with	deterioration;	and	(3)	approaching	death.	The	
emerging	findings	were	discussed	with	the	multi-	disciplinary	research	
team	at	regular	intervals.	Quotes	are	used	to	illustrate	the	main	themes.
3  | RESULTS
3.1 | Sample characteristics
Table	1	 presents	 the	 demographics	 of	 the	 patient	 participants,	 the	
time	from	diagnosis	to	recruitment	and	the	timing	of	the	interviews.	
The	patient	 sample	 comprised	of	10	men	and	6	women,	 ranging	 in	
age	 from	48	 to	 80	years.	 Eleven	 participants	 presented	with	meta-
static	disease	at	diagnosis.	The	median	time	from	diagnosis	of	meta-
static	cancer	 to	recruitment	was	9	months	 (range	2–15	months).	All	
loss	to	follow	up	resulted	from	death.	A	total	of	36	interviews	were	
conducted	(including	14	where	the	carer	was	present	at	the	patent’s	
request)—16,	13	and	7	at	interview	points	one,	two	and	three	respec-
tively,	 ranging	 in	 length	 from	 30	 to	 120	min	 were	 conducted	 over	
1 year.
3.2 | Theme 1: Diagnosis and initial treatment
All	 participants	narrated	 the	 lead	up	 to	 the	diagnosis,	 receiving	 the	
diagnosis	and	initial	treatment.	Some	described	incidences	of	delayed	
diagnosis	which	left	them	feeling	fearful,	abandoned	and	wondering	if	
the	delay	could	have	led	to	more	extensive	disease.	Those	diagnosed	
with	metastatic	disease	sometimes	described	disbelief.
I was absolutely gob smacked, I mean I knew it was 
there but I never expected it to be so extensive (Deirdre, 
66 years, interview 1)
Participants	had	endured	major	surgery	to	remove	the	primary	tu-
mour	in	the	bowel,	then	undergone	chemotherapy.	Surgery	was	some-
times	described	as	a	relief,	if	participants	felt	that	something	was	being	
done.	For	others,	it	marked	the	beginning	of	a	long,	but	hopeful	road	to	
recovery.	The	emergency	nature	of	 the	 surgery	 for	bowel	obstruction	
meant	some	participants	suddenly	faced	their	own	mortality.
Die or don’t. That’s how bad it was, if you don’t get it you 
could die and if you do get it you could die. So what choice 
do you have? (Brenda, 60 years, interview 1)
All	participants	had	received	chemotherapy,	but	in	spite	of	the	com-
plications,	participants	described	it	as	encouraging	that	something	was	
being done.
But I kinda panicked when they stopped it (chemotherapy) 
because I’m saying that’s getting me better you know? 
(Faye, 55 years, interview 1)
All	patients	had	been	told	that	their	disease	was	incurable,	yet	many	
initially	said	they	still	hoped	to	be	cured.	This	was	attributable	to	treat-
ment	with	chemotherapy	by	some.	They	were	uncertain	about	how	long	
they	had	left	to	live	and	what	their	quality	of	life	would	be.	As	a	result	
of	this	they	developed	strategies	to	cope	with	uncertainty,	such	as	de-
veloping	their	own	parameters	of	illness	and	wellness,	which	they	used	
to	subjectively	monitor	their	progress	between	visits	to	the	outpatient	
clinic.	For	example,	weight,	and	the	presence	or	absence	of	pain,	were	
subjectively	monitored	between	appointments	and	was	seen	by	partici-
pants	as	a	tangible	indicator	of	their	progress.
I’m happy with myself because I havenae got any bleeding 
or anything like that. I suffer a wee bit of constipation erm 
but I’m no in pain (Faye, 55 years, interview 1)
Overall,	participants	tried	to	maintain	as	normal	a	life	as	possible	by	
continuing	to	work,	satisfy	their	hobbies	and	socialise	with	friends.
I just cope by trying to act really normal you know and 
just try not to think about it although you know obviously 
about an hour or so doesn’t go past where I don’t think 
about it but I try and just, you know. I’m at work all day 
and my colleagues are great (Cath, 48 years, interview 1)
However,	as	the	cancer	progressed,	socialising	became	more	difficult	
due	to	frequency	of	hospital	appointments,	bowel	unpredictability,	tired-
ness	and	the	side	effects	of	chemotherapy.	The	illness	also	put	a	strain	
on	relationships—one	participant	described	being	well	supported	by	her	
family	and	friends,	but	that	no	one	could	fully	understand	how	she	felt.
3.3 | Theme 2: Deterioration
During	the	second	interviews,	patients	spoke	of	disease	progression,	
their	 treatment,	 how	 their	 social	 world	 was	 contracting	 and	 their	
thoughts	about	the	future.	In	spite	of	the	initial	treatment,	nearly	all	
the	participants	described	deterioration	in	their	condition,	such	as	epi-
sodes	of	pain.	Changes	to	physical	appearance	meant	the	cancer	was	
more	visible	to	others—for	example,	weight	changes	due	to	cachexia	
or	steroids,	and	hair	loss	due	to	chemotherapy.
Well I think sometimes when people look at you I think, 
and I’ll maybe be wrong here, but sometimes when peo-
ple know that you’ve sort of got cancer there, sort of, I 
don’t know if they avoid you or they stand back (Andrew, 
57 years, interview 2)
Following	extensive	abdominal	surgery,	Ann	no	 longer	felt	 like	her	
old	self,	and	she	too	was	worried	about	how	her	physical	appearance	
would	alter	her	personal	relationships.
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You can understand how demoralising that is, and how 
totally disgusted I am. I can’t go and visit friends like that. 
Even though they would understand, well would they, you 
know? (Ann, 67 years, interview 2)
Male,	more	 than	 female	 participants,	 expressed	 a	 desire	 to	 ‘fight’	
the	cancer;	often	for	 the	sake	of	others.	Some	took	hope	 from	previ-
ous	experiences	to	fuel	their	positive	outlook.	For	example,	Gordon	was	
encouraged	that	in	the	past	he	had	been	given	good	news	at	the	clinic,	
so	he	expected	it	again.	John	had	already	survived	18	months	which	he	
considered	a	positive	sign.
I mean, I’ve survived 18 months plus, because there’s the 
time before when I had the cancer and I didn’t know about 
it. So I mean, I’m 18 months down the line and I didn’t 
think I’d be 18 months down the line to be honest with 
you. I mean, when somebody tells you you’ve got cancer 
you think “oh shit” you know – excuse my French! (John, 
62 years, interview 2)
Treatment	played	a	vital	role	as	 it	enabled	participants	to	feel	that	
they	were	being	actively	cared	for,	as	opposed	to	feeling	abandoned.	In	
spite	of	their	incurable	status,	treatment	brought	hope,	as	the	quote	from	
Andrew illustrates.
the doctor said there would be other drugs, if it was neces-
sary we could use them as well. But the chemo itself seems 
to be shrinking it (Andrew, 57 years, interview 2)
Maintaining	this	positive	exterior	was	difficult,	and	participants	ex-
pressed	that	the	thought	of	dying	was	at	the	back	of	their	minds.
when they [family] all go away, you can come down be-
cause you’re being so positive. But there’s also that nag-
ging at the back of your head that it’s not. (Faye, 55 years, 
interview 2)
Existential	aspects	of	the	experience	became	more	obvious	at	inter-
view	2,	as	many	participants	were	consumed	by	thoughts	of	what	the	
future	would	hold	for	them.
I try not to think about it anymore than I can help. I mean, 
it’s generally in my bed at night and my brain starts whirl-
ing, sometimes in the morning as well when I wake up 
(Deirdre, 66 years, interview 2)
Akin	 to	 the	 findings	 in	 the	 first	 interviews,	 participants’	 thoughts	
of	the	future	were	veiled	by	feelings	of	uncertainty.	Although	each	had	
been	told	the	cancer	was	not	curable,	participants	were	uncertain	about	
how	the	illness	would	progress	and	what	their	future	would	hold,	even	
hoping	they	may	avoid	their	likely	fate.	However,	some	participants	had	
started	planning	for	dying	with	their	relatives.
And we were talking about that, my sister and I, I says 
‘well, to be honest, I’m not wanting that [to die at home] 
for anybody’ I says ‘I’d just go into the hospital’ (Faye, 
55 years, interview 2)
Participants	 expressed	 concern	 about	what	material	 and	 an	 emo-
tional	legacy	they	were	leaving	their	families.	Many	participants	wanted	
to	 know	 that	 their	 lives	 had	 been	 meaningful.	 For	 example,	 Duncan	
wanted	to	be	remembered	fondly	by	people.
I mean, the most important thing is for people to turn 
around when it’s your time to move on and they say ‘well, 
your dad was a gentleman’ (Duncan, 57 years, interview 2)
3.4 | Theme 3: Last months of life
At	 the	 time	 of	 the	 third	 interviews,	 most	 participants	 were	 more	
openly	acknowledging	their	days	were	numbered.	Considerable	physi-
cal	deterioration	was	reported	and	existential	issues	were	more	read-
ily	expressed.	Participants	spoke	of	death	with	more	certainty.	Home	
became	a	more	meaningful	place,	where	family,	friends	and	memories	
were	kept	alive.	Several	participants	spoke	of	dying	at	home	in	a	fa-
miliar	and	secure	place.	Chris	wished	 to	 stay	at	home	providing	his	
wife	could	cope.
If it’s not going to be too much for Hazel, that’s the only 
thing. If it’s going to be too much for her I’ll just go into 
the hospital. But she’s coping alright. (Chris, 80 years, in-
terview 3)
Physical	deterioration	brought	increasing	weakness,	dependency	and	
social	isolation.	Participants	expressed	a	desire	to	maintain	a	semblance	
of	normality	in	their	lives,	but	illness	progression	made	this	increasingly	
difficult.	Patients	spoke	about	their	inability	to	socialise,	maintain	old	and	
develop	new	relationships.	They	worried	about	becoming	a	burden	on	
their	family	and	friends.	Many	described	losing	confidence	in	their	bod-
ies,	but	treatment	with	chemotherapy	(which	was	universally	palliative)	
or	a	possible	new	treatment	discovery	were	considered	the	only	lifelines	
and	enabled	some	participants	to	remain	falsely	hopeful	of	survival.
they [health professionals] also said at the time “there 
might be something that comes along, you never know” so 
therefore that’s in the back of your mind as well (Andrew, 
57 years, interview 3)
Waiting	to	be	told	that	death	was	imminent	was	consuming	the	at-
tention	of	many	participants.	 Some	were	 imminently	 dying,	 and	palli-
ative	care	had	been	 initiated	 to	manage	 the	 last	 few	weeks	at	home.	
However,	Ian	had	been	given	a	2-	year	prognosis	at	the	time	of	his	diag-
nosis,	so	as	far	as	he	was	concerned,	he	was	approaching	the	end	when	
he	 reached	18	months.	 In	 comparison,	Andrew	had	 not	 been	 given	 a	
prognosis	in	terms	of	months	or	years,	but	had	devised	his	own	strategy	
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for	dealing	with	the	uncertainty	of	his	future	by	setting	goals	of	things	he	
wanted	to	achieve	or	events	he	wanted	to	attend.
4  | DISCUSSION
4.1 | Summary
Patients	 with	 metastatic	 colorectal	 cancer	 have	 complex	 progres-
sive	 physical	 symptoms,	 substantial	 treatment	 burdens	 and	 multi-	
dimensional	 needs.	 They	 also	 experience	 progressive	 psychological,	
social	and	existential	challenges.	Their	experience	was	similar	to	that	
previously	described	in	patients	with	advanced	lung	and	brain	cancer	
(Cavers	et	al.,	2012;	Kendall	&	Murray,	2005)	in	that	there	was	a	clear	
beginning	to	the	story,	and	contrasted	to	narratives	of	patients	with	
chronic	obstructive	pulmonary	disease	and	heart	failure	(Kendall	et	al.,	
2015;	Murray	et	al.,	2007;	Pinnock	et	al.,	2011).	An	understanding	of	
the	difference	between	public	and	private	accounts	which	patients	tell	
clinicians,	and	the	 importance	of	current	social	narratives	of	cancer,	
was	vital	for	understanding	the	results	of	this	study.
Over	 time	 the	 psycho-	social	 and	 spiritual	 aspects	 of	 the	 illness	
played	a	significant	role,	as	people	sought	meaning	in	life	and	relation-
ships	(Simon	et	al.,	2008).	Participants	strived	to	maintain	their	sense	
of	 self	 through	 diagnosis,	 as	 they	 deteriorated,	 and	 through	 death.	
Consistent	with	the	findings	of	other	studies,	at	diagnosis,	participants	
tried	 to	make	 sense	 of,	 and	 accommodate	 the	 cancer	 in	 their	 lives	
(Ramfelt	et	al.,	2002)	and	maintain	a	semblance	of	normality	 (Taylor,	
Richardson,	 &	 Cowley,	 2010),	 but	 over	 time	 became	 increasingly	
isolated	and	 their	 social	world	 contracted	 (Little	et	al.,	 1998;	Taylor,	
2001).
Narratives	of	uncertainty	dominated	the	accounts,	despite	being	
told	 that	 their	 cancer	was	 incurable	 and	 death	 inevitable.	This	 sup-
ports	previous	 reports	describing	uncertainty	 throughout	 the	 illness	
journey	and	in	relation	to	the	future,	families,	treatment,	coping	mech-
anisms,	worsening	 illness	 (Beaver	 et	al.,	 2010;	 Browne	 et	al.,	 2011;	
McCaughan	 et	al.,	 2011;	 Shaha,	 Cox,	 Talman,	 &	 Kelly,	 2008;	 Taylor	
et	al.,	2010).	Feeling	uncertain	is	common	to	the	experience	of	many	
diseases	 (Etkind,	Bristow,	Bailey,	Selman,	&	Murtagh,	2016;	Kimbell,	
Boyd,	 Kendall,	 Iredale,	 &	 Murray,	 2015;	 Taylor,	 Wells,	 Hubbard,	 &	
Worth,	2016).	Recent	research	has	shown	that	uncertainty	is	related	
to	the	participants’	engagement	with	the	 illness	process,	 that	 is,	 the	
extent	to	which	they	take	control	or	cede	control	to	professionals	and	
their	level	of	understanding	of	what	is	often	complex	disease	trajec-
tory	(Etkind	et	al.,	2016).	In	our	study,	uncertainty	was	expressed	in-
creasingly,	over	time,	as	the	impact	of	feeling	uncertain,	yet	certain	of	
death,	emerged.	This	competing	story	of	an	uncertain	prognosis	with	
a	 certain	 outcome,	which	 developed	over	time,	 left	patients	 feeling	
“betwixt	and	between”	(Hockey,	2002;	Van	Gennep,	1960).
The	findings	suggest	that	participants	did	know	they	were	dying,	
but	 this	 was	 not	 necessarily	 expressed	 until	 the	 later	 interviews.	
This	 contrasts	 with	 recent	 research	 that	 reported	 81%	 of	 patients	
with	colorectal	cancer	hoped	that	their	palliative	chemotherapy	was	
going	to	cure	them	(Weeks	et	al.,	2012).	The	high	number	in	this,	and	
some	other	studies,	may	be	due	 to	patients	expressing	 their	 “public	
accounts,”	while	our	serial	in-	depth	interviews	managed	to	access	their	
private	accounts.
This	study	identifies	potential	explanations	why	the	public	narra-
tive	may	 be	 often	 told	 by	 patients	 and	 captured	 in	 quantitative	 re-
search.	Treatment	with	palliative	chemotherapy	can	be	understood	by	
patients	as	a	possible	lifeline.	This	hopeful,	but	unrealistic,	narrative	is	
taken	up	and	continued	by	the	clinician,	as	it	is	easier	to	have	a	hopeful	
conversation,	than	take	time	to	explore	the	more	complex,	existential	
challenges	that	the	participants	described.	We	found	that	participants	
did	not	necessarily	speak	of	palliative	chemotherapy	extending	their	
lives	or	managing	their	symptoms	in	the	interviews,	but	ending	treat-
ment	was	 seen	 as	 a	 sign	 that	 health	 professionals	 had	 given	 up	 on	
them.
The	narrating,	and	listening,	to	idealised	public	accounts	of	illness	
can	be	potentially	problematic.	It	promotes	survivorship,	of	‘fighting’	
cancer.	This	“folie	a	doux”	inhibits	patients	and	professionals	discuss-
ing	 early	 palliative	 care	 and	 advance	 care	 planning	 (Wright,	 Zhang,	
Keating,	Weeks,	&	Prigerson,	2014).
4.2 | Implications
There	are	 implications	for	oncologists,	palliative	care	specialists	and	
generalists	 in	 terms	 of	 communication	 and	 advance	 care	 planning.	
Health	 professionals	 need	 to	manage	 uncertainty	 through	 the	 pro-
vision	 of	 information,	 including	 that	 the	 prognosis	 is	 often	 unclear.	
Managing	expectations	 and	helping	 those	with	 colorectal	 cancer	 to	
plan	 for	 the	 future	may	 reduce	 feelings	of	doubt	and	 insecurity	 to-
wards	the	end	of	life.	The	findings	of	this	research	highlight	the	poten-
tial	of	multi-	disciplinary	involvement,	including	palliative	care	teams,	
and	 good	 communication	 about	 the	 intent	 and	 limits	 of	 treatment,	
which	have	been	discussed	with	the	patient.	Ending	palliative	chemo-
therapy	is	a	critical	time	on	the	illness	trajectory	of	people	with	cancer,	
and	active	 support	 should	be	 triggered,	 if	 not	 already	 in	place.	The	
offer	of	ongoing	care	and	support	during	and	following	chemotherapy	
may	allow	a	realistic	transition	to	discussing	goals	of	care,	and	allow	
care	planning	to	be	more	patient	centred.	Currently,	palliative	care	is	
not	always	seen	as	an	active	and	alternative	treatment	option,	rather	
as	 planning	 for	 dying,	 which	 is	 an	 unattractive	 option	 for	 patients.	
Changing	this	will	enable	patients	to	simultaneously	receive	chemo-
therapy	and	palliative	care.
4.3 | Strengths and limitations
We	could	find	no	other	serial	in-	depth	interview	studies	of	patients	
dying	with	metastatic	 colorectal	 cancer.	 The	 longitudinal	 approach	
permitted	the	researcher	to	follow	participants	as	they	deteriorated,	
so	those	in	the	last	months	of	life	were	represented.	The	design	en-
abled	 prospective,	 retrospective	 and	 real-	time	 accounts	 of	 experi-
ence,	where	participants	moved	beyond	public	accounts	of	illness	to	
reveal	their	private	thoughts	and	fears	(Cornwell,	1984;	Murray	et	al.,	
2009).	Therefore,	 the	 study	was	not	based	 solely	on	 retrospective	
accounts	 of	 experience.	No	 participants	withdrew	 from	 the	 study,	
which	 suggests	 that	 the	mode	 of	 recruitment	 and	 the	 longitudinal	
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method	was	acceptable	to	participants.	Regular	research	team	meet-
ings	 were	 conducted	 to	 ensure	 adequate	 reflection	 time	 and	 to	
consider	 the	 boundaries	 of	 the	 researcher/participant	 relationship.	
Managing	and	analysing	the	large	dataset	was	complex.	It	is	for	this	
reason	that	there	is	a	drive	to	promote	secondary	analysis	of	the	rich,	
qualitative	data	which	arise	from	longitudinal	work.	The	data	gener-
ated	from	this	study	continues	to	be	used	in	this	way	(Kendall	et	al.,	
2015).
This	 study	 affords	 a	 rich,	 contextualised	 account	 of	 the	 experi-
ences	of	this	group	of	participants.	Different	accounts	may	have	been	
heard	had	different	participants	been	recruited,	at	a	different	time,	and	
from	a	different	place,	or	ethnic	of	cultural	grouping.	Also,	those	with	
a	permanent	stoma	were	under-	represented.	However,	the	generalis-
ability	to	other	populations	is	best	considered	by	comparing	the	con-
texts	(Polit	&	Beck,	2010).	Patients	were	not	asked	about	which	aspect	
of	care	they	might	prioritise,	so	a	further	study	is	 indicated	before	a	
pilot	intervention	may	be	tested	to	do	this.
5  | CONCLUSIONS
Living	 and	 dying	 with	 advanced	 colorectal	 cancer	 is	 multi-	faceted;	
patients	have	in	their	minds	contradictory	accounts	of	certainty	and	
uncertainty,	recovery	and	death,	hope	and	despair.	Patients	express	
one	or	other	of	these	to	clinicians	and	researchers	according	to	how	
safe	or	secure	they	may	feel	and	their	relationship	with	the	enquirer.	
Good	communication,	the	provision	of	information	and	shared	deci-
sion	making	are	 important	to	help	reduce	feelings	of	anxiety	and	to	
enable	patients	to	voice	their	fears,	and	prepare	for	the	future	through	
and	after	their	deaths.	A	palliative	care	approach,	which	encourages	
holistic	 care	 to	 enable	 those	who	 are	 dying	 to	maintain	 a	 sense	 of	
meaning	and	purpose,	should	be	integrated	into	oncological	and	pri-
mary	care	from	diagnosis	of	advanced	disease.
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